VANGUARD GROUP INC - ONCOGENEX PHARMACEUTICALS IN ownership

ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106. A total of 55 filers reported holding ONCOGENEX PHARMACEUTICALS IN in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of ONCOGENEX PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2017$212,000
-28.6%
588,568
-12.7%
0.00%
Q1 2017$297,000
-11.6%
674,078
+0.4%
0.00%
Q4 2016$336,000
-14.1%
671,278
-12.9%
0.00%
Q3 2016$391,000
-53.5%
770,960
-8.3%
0.00%
Q2 2016$841,000
+46.3%
840,7440.0%0.00%
Q1 2016$575,000
-37.5%
840,744
+10.6%
0.00%
Q4 2015$920,000
-45.6%
760,278
+0.1%
0.00%
Q3 2015$1,692,000
+47.3%
759,145
+53.8%
0.00%
Q2 2015$1,149,000
+14.8%
493,469
+6.0%
0.00%
Q1 2015$1,001,000
+4.3%
465,498
+11.0%
0.00%
Q4 2014$960,000
-11.1%
419,357
+3.7%
0.00%
Q3 2014$1,080,000
-15.0%
404,585
+18.9%
0.00%
Q2 2014$1,270,000
-66.8%
340,393
+4.6%
0.00%
Q1 2014$3,827,000
+115.5%
325,397
+52.8%
0.00%
Q4 2013$1,776,000
-30.4%
212,992
-22.6%
0.00%
Q3 2013$2,550,000
-5.6%
275,148
-0.2%
0.00%
Q2 2013$2,702,000275,7000.00%
Other shareholders
ONCOGENEX PHARMACEUTICALS IN shareholders Q4 2015
NameSharesValueWeighting ↓
Abingworth LLP 396,104$400,0000.42%
Ancora Advisors LLC 50,865$51,0000.01%
EAGLE GLOBAL ADVISORS LLC 145,710$146,0000.00%
Acrospire Investment Management LLC 5,200$5,0000.00%
A.R.T. Advisors, LLC 57,954$57,0000.00%
Renaissance Technologies 876,100$876,0000.00%
PRELUDE CAPITAL MANAGEMENT, LLC 4,600$5,0000.00%
Cutler Group LLC / CA 11,048$11,0000.00%
PANAGORA ASSET MANAGEMENT INC 133,846$134,0000.00%
PRICE T ROWE ASSOCIATES INC /MD/ 46,100$46,0000.00%
View complete list of ONCOGENEX PHARMACEUTICALS IN shareholders